Arkansas faces a rise in whooping cough cases, prompting concern over vaccination rates, while controversial hepatitis B ...
A newly cleared point-of-care test will enable rapid identification of whooping cough, according to a press release from ...
Infectious diseases including mumps, whooping cough, and scrofula (a neck swelling, often caused by tuberculosis) are more ...
Whopping cough cases in the United States reached levels in 2025 far higher than before and during the Covid-19 pandemic. But ...
As Willamette University is in the midst of its flu season, health officials at the Bishop Wellness Center explained how they ...
Breakthrough new vaccine spray could be first to stop spread of deadly whooping cough which sees infants ‘turn blue’ ...
Roche has received clearance from the US Food and Drug Administration (FDA) for its point of care diagnostic test for ...
A human challenge trial has shown a new vaccine could offer better protection against whooping cough. The new study, ...
After a lull during the COVID-19 pandemic, pertussis (whooping cough) has made a resurgence—especially in adolescents—with ...
A new nasal spray vaccine, BPZE1, shows promise in preventing whooping cough bacteria from residing in the nose and throat.
A new University of Southampton–led human challenge trial has shown that BPZE1, a nasal spray vaccine for whooping cough, can prevent the bacteria from colonising the nose and throat — a first for any ...
Roche’s point-of-care polymerase chain reaction (PCR) test for pertussis and other Bordetella infections has received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback